{Etokimab: A Deep Examination into the 2022981-44-6 Antibody Etokimab, designated by the specific identifier 2022981-44-6, represents a emerging protein currently subject to research evaluation. This therapeutic agent, https://www.targetmol.com/compound/etokimab